Cellulose Chemistry and Technology

ADVANCES IN THE CHEMISTRY, PHYSICS AND TECHNOLOGY
OF PULP, PAPER AND CELLULOSE-BASED MATERIALS

ISSN 2457-9459 (Online)
ISSN-L 0576-9787 (Print)


2023

Journal Citation Reports
Impact factor 2023: 1.3
5-Year Impact Factor: 1.2
Article Influence® Score: 0.140
Ranked 9 out of 23
MATERIALS SCIENCE, PAPER & WOOD (Q2)

Scopus
CiteScore 2023: 2.3
SNIP: 0.405

SCImago
SJR: 0.264
H-Index: 42
Ranked Q3

 

Title
Formulation and evaluation of transferosomal buccal film containing empagliflozin – an antidiabetic agent
Authors
ASHISH P. GORLE, JANHAVI WAGH and SWATI RAYSING

Received July 9, 2026
Published Volume 60 Issue 7-8 July-August
Keywords transferosomes, buccal film, SGLT2 inhibitor, Central Composite Design, in vitro release, in vivo pharmacokinetic evaluation, stability studies

Abstract
Diabetes mellitus is one of the most difficult chronic diseases around the world, and it is as important to discover ways to better deliver antidiabetic drugs as it is to discover them. Empagliflozin is a selective SGLT2 inhibitor that has a restricted therapeutic potential when administered as an oral tablet. To overcome this limitation, it was chosen in this study as a drug to deliver through a transferosomal buccal film. Lipid vesicles (Lipoid S100 and Tween 80) were prepared by the ethanol injection method and optimised using a Central Composite Design. The mean particle size, entrapment efficiency and the zeta potential of the optimized transferosomes were found to be 119 nm, 86% and -28.3 mV, respectively (Batch F4). They were then incorporated into a film prepared by the solvent casting technique using mucoadhesive materials, such as HPMC E5, PVP K30 and PEG 400. The results indicated that Batch B3 was the best batch having the drug content of 97.67%, moisture content of 4.46% and folding endurance of 127. The optimized formulation released 97.85% of drug in vitro in 60 minutes and had ex-vivo buccal permeation that was 18.93% higher than that of a plain film, having a zero-order release profile; also, it was found stable when kept at different temperatures. Most importantly, in-vivo pharmacokinetic evaluation in Sprague Dawley rats further confirmed enhanced systemic absorption, with the transferosomal film showing markedly higher bioavailability (AUC₀₋∞: 8.706 vs. 5.519 µg·h/mL) and Cmax (0.93 vs. 0.56 µg/mL) relative to the plain buccal film.


Link https://doi.org/10.35812/CelluloseChemTechnol.2026.60.71

- Full text available Download



Reviewer Information

Editor Information